Objective To compare the effects of switching from a pressurised metered dose inhaler (pMDI)-based to a dry powder inhaler (DPI)-based maintenance therapy versus continued usual care on greenhouse gas emissions (carbon dioxide equivalents, CO(2)e) and asthma control. ethods This post-hoc analysis was based on a subset of 2236 (53%) patients from the Salford Lung Study in Asthma who at baseline were using a pMDI-based controller therapy. During the study patients were randomised to fluticasone furoate/vilanterol (FF/VI) via the ELLIPTA DPI (switched from pMDI to DPI) (n=1081) or continued their usual care treatment (n=1155), and were managed in conditions close to everyday clinical practice. Annual CO(2)e (kg) was calculated for the total number of maintenance and rescue inhalers prescribed. Asthma control was assessed by the proportion of ACT responders (composite of ACT total score >= 20 and/or increase from baseline >= 3). Results The groups were well matched for demographic characteristics and baseline Asthma Control Test (ACT) total score (mean age: 49 years; mean ACT score: usual care, 16.6; FF/VI, 16.5). Annual CO(2)e kg per patient (maintenance plus rescue therapy) was significantly lower with FF/VI DPI treatment ('switch' group) than usual care (least squares geometric mean 108 kg (95% CI 102 to 114) vs 240 kg (95% CI 229 to 252), p<0.001). Asthma control was consistently superior over the 12 months in the FF/VI DPI group compared with usual care. Conclusions Patients switching from a pMDI-based to a DPI-based maintenance therapy more than halved their inhaler carbon footprint without loss of asthma control. The remaining inhaler carbon footprint could be reduced through switches from pMDI to DPI rescue medications or alternative lower-carbon footprint rescue inhalers if available. Asthma control improved in both groups, with greater control demonstrated in those initiated on FF/VI DPI.
机构:
Guangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R ChinaGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Zheng, Jinping
Zhang, Jianyong
论文数: 0引用数: 0
h-index: 0
机构:
Zunyi Med Univ, Dept Resp & Crit Care Med, Affiliated Hosp, Zunyi, Peoples R ChinaGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Zhang, Jianyong
Fu, Xiuhua
论文数: 0引用数: 0
h-index: 0
机构:
Inner Mongolia Med Univ, Resp Dept, Affiliated Hosp, Hohhot, Peoples R ChinaGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Fu, Xiuhua
Lin, Changqing
论文数: 0引用数: 0
h-index: 0
机构:
Huizhou Cent Peoples Hosp, Dept Resp Med, Huizhou, Peoples R ChinaGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Lin, Changqing
Zhang, Xinri
论文数: 0引用数: 0
h-index: 0
机构:
Shanxi Med Univ, Hosp 1, NHC Key Lab Pneumoconiosis, Shanxi Key Lab Resp Dis, Taiyuan, Peoples R ChinaGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Zhang, Xinri
Mei, Xiaodong
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sci & Technol China, Anhui Prov Hosp, Affiliated Hosp USTC 1, Dept Resp & Crit Care Med, Hefei, Peoples R ChinaGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Mei, Xiaodong
论文数: 引用数:
h-index:
机构:
Corradi, Massimo
Cappellini, Glauco
论文数: 0引用数: 0
h-index: 0
机构:
Chiesi Farmaceut SpA, Global Clin Dev, Parma, ItalyGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Cappellini, Glauco
Calabro, Emanuele
论文数: 0引用数: 0
h-index: 0
机构:
Chiesi Farmaceut SpA, Global Clin Dev, Parma, ItalyGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Calabro, Emanuele
Zhu, Cissy
论文数: 0引用数: 0
h-index: 0
机构:
Chiesi Pharmaceut Consulting Shanghai Co Ltd, Global Clin Dev, Shanghai, Peoples R ChinaGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
Zhu, Cissy
Topole, Eva
论文数: 0引用数: 0
h-index: 0
机构:
Chiesi Farmaceut SpA, Global Clin Dev, Parma, ItalyGuangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China